VBIO ▼ -1.7% - Valion Bio, Inc. $VBIO - Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule Valion Bio shares fell 1.7% despite the company announcing it has regained compliance with NASDAQ's minimum bid price requirement, which had previously put its listing status at risk. The stock's decline suggests investors may have been pricing in earlier uncertainty about the company's ability to meet the exchange's standards, or that the compliance announcement alone was insufficient to drive broader buying interest. 22-SEP-2026 08:00 AM ET